M&A Gathers Steam for Biotech Startups
Wall Street Journal
Mergers and acquisitions of venture-backed drug developers are starting to rebound following a relatively slow period in 2023, brightening the outlook for venture capitalists seeking to cash out of biotechnology investments.
https://www.wsj.com/articles/m-a-gathers-steam-for-biotech-startups-32a71d59